Elite in Urea Cycle Disorders (UCD)
Check Dr. George A. Diaz's experience treating your condition:
About Dr. George A. Diaz

George Diaz is a Pediatrics specialist and a Medical Genetics expert in New York, New York. Diaz has been practicing medicine for over 29 years and is rated as an Elite expert by MediFind in the treatment of Urea Cycle Disorders (UCD). He is also highly rated in 17 other conditions, according to our data. His top areas of expertise are Urea Cycle Disorders (UCD), Inborn Amino Acid Metabolism Disorder, Arginase Deficiency, and Ornithine Transcarbamylase Deficiency. He is licensed to treat patients in New York. Diaz is currently accepting new patients.

His clinical research consists of co-authoring 88 peer reviewed articles and participating in 14 clinical trials in the past 15 years. In particular, he has co-authored 29 articles and participated in 10 clinical trials in the study of Urea Cycle Disorders (UCD).


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. George A. Diaz it is best to call his office and ask if your insurance is accepted.

Accepts Medicare
New York, NY 10029
Background & Education
Graduate Institution
State University Of Ny Upstate Medical University, 1994
Medical Genetics
Pediatrics in NY
Hospital Affiliations
Mount Sinai Morningside
Mount Sinai Beth Israel
Mount Sinai Medical Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
A Phase 3 Open-Label Extension Study of PTC923 in Phenylketonuria
Longitudinal Study of Urea Cycle Disorders
Orphan Europe Carbaglu® Surveillance Protocol
Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia
An Open-label Study of the Efficacy and Safety of SYNB1618 and SYNB1934 in Patients With Phenylketonuria (SynPheny-1)
View 8 Less Clinical Trials -

88 Total Publications

One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors